Dr Bozena B Jurek, MD | |
5059 W 111th St, Alsip, IL 60803-6074 | |
(708) 425-1300 | |
(708) 425-3443 |
Full Name | Dr Bozena B Jurek |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 5059 W 111th St, Alsip, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568453777 | NPI | - | NPPES |
1295853380 | Other | IL | GROUP NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bozena B Jurek, MD 5059 W 111th St, Alsip, IL 60803-6074 Ph: (708) 425-1300 | Dr Bozena B Jurek, MD 5059 W 111th St, Alsip, IL 60803-6074 Ph: (708) 425-1300 |
News Archive
Euthymics Bioscience, Inc., a privately held Delaware corporation, today announced that it has signed a non-binding Letter of Intent (LOI) to merge into and acquire DOV Pharmaceutical, Inc. (DOV), a Delaware corporation currently traded on the Pink Sheets, for $2.0 million in cash plus payment of certain of DOV's expenses. DOV believes that the contemplated $2.0 million cash payment to shareholders represents approximately $0.015 per share of DOV common stock. If the transaction is consummated, it is anticipated that DOV will be renamed Euthymics Bioscience, Inc.
Half of all people of South Asian, African and African Caribbean descent will develop diabetes by age 80 according to a new study published today. The study is the first to reveal the full extent of ethnic differences in the risk of developing type 2 diabetes and also provides some answers as to the causes of the increased risk.
Based on a systematic analysis of trials related to rheumatoid arthritis and psoriasis arthritis, a MedUni Vienna study group at the Division of Rheumatology at MedUni Vienna/Vienna General Hospital was able to show that many clinical phase II trials systematically overestimate the efficacy of therapeutics, so that the results of subsequent phase III trials can often be disappointing. Essentially this situation also applies in many other areas.
Seventy-four percent of those enrolled in the Federal Health Benefits Program (FEHBP) oppose a new effort by Congress to change the program's prescription drug benefits, according to a new poll released by the Pharmaceutical Care Management Association.
› Verified 4 days ago
Ankita Dalal, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12246 S Pulaski Rd, Alsip, IL 60803 Phone: 708-385-5601 Fax: 708-396-3802 | |
Dr. Amit Garg, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6195 W 115th St Ste A, Alsip, IL 60803 Phone: 312-262-7002 Fax: 312-262-7005 |